Donepezil, an acetylcholinesterase inhibitor (AChEI), has been widely used to treat Alzheimer’s disease (AD) in China (Zhang and Gordon, 2018), so we used donepezil as the positive control in the present study. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.